Dr. Elan Cohen is a PI at Hassman Research Institute with ample experience in rater training and data surveillance. He is also significantly engaged in research exploring various interventions aimed at systemically reducing the insidious placebo and nocebo effects within clinical trials (http://www.hritrials.com/hri-science-division-2/). Dr. Cohen conducted two separate presentations to attendees from each Alliance site…

Thanks to all who participated in our recent webinar, “Driving Impairment: Avoiding Roadblocks in Drug Development.” If you missed it, a recording of the presentation is available. If you have a compound in development that has potential to impair driving ability, this is necessary information. Attending DIA or ASCP? Don’t miss the chance to experience…

BERLIN, NJ, April 23, 2019 — We are pleased to announce that Steven J. Glass, M.D. has joined Hassman Research Institute (HRI) as Psychiatric Medical Director. Dr. Glass received his medical degree from Thomas Jefferson Medical College in Philadelphia (now Sidney Kimmel Medical College of Jefferson University) where he also completed his psychiatric residency and…

Clinical Trial Centers Alliance, an elite group of independent sites and services, is pleased to announce the addition of Exemplar Research, Inc., a community-based, independent Regional Investigative Clinical Research Site Network, serving West Virginia and the surrounding region. Exemplar will benefit from the resources of the Alliance’s successful history serving hundreds of sponsors, CROs and…

Texas Neurological Society (TNS) will honor John D. Hudson, M.D., Principal Investigator at FutureSearch Trials of Neurology, with its 2020 Lifetime Achievement Award during its 2020 Winter Conference. The TNS Lifetime Achievement Award is a peer-recognition award honoring a member in the state for outstanding service to patients and the specialty. Dr. Hudson was selected…

One of the key aspects that link all of the Alliance sites is their unwavering commitment to be perpetually and systemically conscious of how the placebo effect intrudes on their hard work enrolling quality subjects into trials as well as rating subjects on their severity indication throughout subject study participation. From site Principal Investigators, Sub-Investigators,…

2018 was a wildly busy year for the Alliance. Check out these stats on our activities last year.

Two of the Alliance sites, Hassman Research Institute (HRI) and Collaborative Neuroscience Network (CNS), collaborated to develop a self-funded empirical investigation assessing how a Placebo-Control Reminder Script (PCRS) educating subjects about key factors associated with placebo response in clinical trials might help manage this insidious effect within our industry. They presented their positive results at…

October 15-16, Alliance representatives are attending the International Society for CNS Clinical Trials and Methodology (ISCTM) Autumn Conference in Marina del Ray, CA.   November 1-4, we’ll be in Boca Raton, FL for CNS Summit.   We look forward to hearing from knowledgeable speakers, and meeting with industry associates to discuss our capabilities and extensive…